VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+87.69%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(+31%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-157.22%
Top 10 Holdings %
Top 10 Hldgs %
92.87%
Holding
27
New
6
Increased
2
Reduced
4
Closed
6
Top Buys
| 1 |
Outlook Therapeutics
OTLK
|
$5.97M |
| 2 |
TELA Bio
TELA
|
$3.79M |
| 3 |
Aquestive Therapeutics
AQST
|
$2.56M |
| 4 |
Milestone Pharmaceuticals
MIST
|
$1.16M |
| 5 |
Rezolute
RZLT
|
$1.02M |
Top Sells
| 1 |
Jasper Therapeutics
JSPR
|
$279M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$5.62M |
| 3 |
Roivant Sciences
ROIV
|
$5.62M |
| 4 |
Lantheus
LNTH
|
$4.65M |
| 5 |
ADMA Biologics
ADMA
|
$4.01M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
1
DELISTED
Alimera Sciences, Inc.
ALIM
| $53.1M | 24.1% | 13,608,533 | – | – |
|
|
2
Jasper Therapeutics
JSPR
$45.5M
| $42.1M | 19.12% | 1,471,904 -9,747,132 | -87% | -$279M |
|
3
Praxis Precision Medicines
PRAX
$958M
| $21.4M | 9.72% | 350,666 +5,000 | +1% | +$305K |
|
4
Heron Therapeutics
HRTX
$207M
| $19.4M | 8.79% | 6,986,744 | – | – |
|
|
5
ADMA Biologics
ADMA
$4.12B
| $10.1M | 4.58% | 1,528,601 -607,499 | -28% | -$4.01M |
|
6
Tourmaline Bio
TRML
$601M
| $7.31M | 3.32% | 319,080 | – | – |
|
|
7
Outlook Therapeutics
OTLK
$37.8M
| $5.97M | 2.71% | +500,000 | New | +$5.97M |
|
|
OPTN
8
DELISTED
OptiNose
OPTN
| $4.38M | 1.99% | 3,001,191 -795,670 | -21% | -$1.16M |
|
|
9
TELA Bio
TELA
$70.5M
| $4.23M | 1.92% | 746,087 +668,587 | +863% | +$3.79M |
|
10
Inspire Medical Systems
INSP
$2.77B
| $3.87M | 1.76% | 18,000 | – | – |
|
|
11
Aquestive Therapeutics
AQST
$456M
| $2.56M | 1.16% | +600,000 | New | +$2.56M |
|
|
ELEV
12
DELISTED
Elevation Oncology
ELEV
| $2.55M | 1.16% | 497,299 | – | – |
|
13
InspireMD
NSPR
$102M
| $2.14M | 0.97% | 904,029 | – | – |
|
14
Geron
GERN
$893M
| $1.65M | 0.75% | 500,000 -278,500 | -36% | -$919K |
|
|
15
Milestone Pharmaceuticals
MIST
$156M
| $1.16M | 0.53% | +650,000 | New | +$1.16M |
|
|
16
Rezolute
RZLT
$619M
| $1.02M | 0.46% | +400,000 | New | +$1.02M |
|
17
enVVeno Medical
NVNO
$15.4M
| $937K | 0.43% | 172,235 | – | – |
|
18
Kiora Pharmaceuticals
KPRX
$9.55M
| $777K | 0.35% | +1,100,000 | New | +$777K |
|
|
ASLN
19
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $385K | 0.17% | +625,000 | New | +$385K |
|
20
Aclaris Therapeutics
ACRS
$209M
| – | – | -1,761,595 | Closed | -$1.85M |
|
21
Apellis Pharmaceuticals
APLS
$3.48B
| – | – | -50,000 | Closed | -$2.99M |
|
22
Immunovant
IMVT
$2.56B
| – | – | -27,500 | Closed | -$1.16M |
|
23
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
|
24
Lantheus
LNTH
$3.73B
| – | – | -75,000 | Closed | -$4.65M |
|
|
25
Roivant Sciences
ROIV
$8.15B
| – | – | -500,000 | Closed | -$5.62M |
|